Covid-19 vaccine shows encouraging results, 94% of human trial successful

Scientists around the world are working day and night to develop a drug to fight the corona virus. So far, many companies have only claimed to have developed the vaccine. But the vaccine is considered successful only if the clinical trial on humans is successful.

According to the information received, the American pharmaceutical company Inovio has conducted a successful clinical trial of its vaccine INO-4800 on humans.

The vaccine was tested on about 40 people. Best of all, the drug has a 94 percent success rate. Scientists believe that the new vaccine works in a special way. The vaccine is injected into the body.

This drug is a type of DNA that builds up the body's immune system against the corona virus.

It is the US President Donald Trump who has hired Inovio company to develop the coronavirus vaccine as soon as possible. The trial of the new vaccine has already received FDA approval. Under the plan, the company will produce 300 million vaccines by January next year.